Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1078938

Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019

(European IVE Grp) Kissling, Esther; ….; Filipovic, Sanja Kurecic; Visekruna-Vucina, Vesna; Novosel, Iva Pem; Lovric, Zvjezdana; Petrovic, Goranka; Drazenovic, VladimirVince, Adriana; Topic, Antea; Mihalic, Jelena Budimir et al.
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019 // Eurosurveillance, 24 (2019), 8; 1900121, 23 doi:10.2807/1560-7917.ES.2019.24.1900121 (međunarodna recenzija, kratko priopcenje, ostalo)

CROSBI ID: 1078938 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019

Autori
Kissling, Esther ; …. ; Filipovic, Sanja Kurecic ; Visekruna-Vucina, Vesna ; Novosel, Iva Pem ; Lovric, Zvjezdana ; Petrovic, Goranka ; Drazenovic, VladimirVince, Adriana ; Topic, Antea ; Mihalic, Jelena Budimir ; Huljev, Eva ; Luksic, Boris ; Karabuva, Svjetlana ; Cikes, Mihaela ; … ; Zambon, Maria

Kolaboracija
European IVE Grp

Izvornik
Eurosurveillance (1025-496X) 24 (2019), 8; 1900121, 23

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, kratko priopcenje, ostalo

Ključne riječi
Europe ; influenza ; multicentre study ; test-negative design ; vaccination ; vaccine effectiveness ; vaccines and immunisation
(Europe ; influenza ; multicentre study ; test-negative design ; vaccination ; vaccine effectiveness ; vaccines and immunisation.)

Sažetak
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018–January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32–43% against influenza A ; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34–38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
KBC Split,
Medicinski fakultet, Split

Profili:

Avatar Url Vesna Višekruna Vučina (autor)

Avatar Url Svjetlana Karabuva (autor)

Avatar Url Goranka Petrović (autor)

Poveznice na cjeloviti tekst rada:

doi www.eurosurveillance.org

Citiraj ovu publikaciju:

(European IVE Grp) Kissling, Esther; ….; Filipovic, Sanja Kurecic; Visekruna-Vucina, Vesna; Novosel, Iva Pem; Lovric, Zvjezdana; Petrovic, Goranka; Drazenovic, VladimirVince, Adriana; Topic, Antea; Mihalic, Jelena Budimir et al.
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019 // Eurosurveillance, 24 (2019), 8; 1900121, 23 doi:10.2807/1560-7917.ES.2019.24.1900121 (međunarodna recenzija, kratko priopcenje, ostalo)
(European IVE Grp) (European IVE Grp) Kissling, E., …., Filipovic, S., Visekruna-Vucina, V., Novosel, I., Lovric, Z., Petrovic, G., Drazenovic, VladimirVince, Adriana, Topic, A. & Mihalic, J. (2019) Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. Eurosurveillance, 24 (8), 1900121, 23 doi:10.2807/1560-7917.ES.2019.24.1900121.
@article{article, author = {Kissling, Esther and Filipovic, Sanja Kurecic and Visekruna-Vucina, Vesna and Novosel, Iva Pem and Lovric, Zvjezdana and Petrovic, Goranka and Topic, Antea and Mihalic, Jelena Budimir and Huljev, Eva and Luksic, Boris and Karabuva, Svjetlana and Cikes, Mihaela and Zambon, Maria}, year = {2019}, pages = {23}, DOI = {10.2807/1560-7917.ES.2019.24.1900121}, chapter = {1900121}, keywords = {Europe, influenza, multicentre study, test-negative design, vaccination, vaccine effectiveness, vaccines and immunisation}, journal = {Eurosurveillance}, doi = {10.2807/1560-7917.ES.2019.24.1900121}, volume = {24}, number = {8}, issn = {1025-496X}, title = {Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019}, keyword = {Europe, influenza, multicentre study, test-negative design, vaccination, vaccine effectiveness, vaccines and immunisation}, chapternumber = {1900121} }
@article{article, author = {Kissling, Esther and Filipovic, Sanja Kurecic and Visekruna-Vucina, Vesna and Novosel, Iva Pem and Lovric, Zvjezdana and Petrovic, Goranka and Topic, Antea and Mihalic, Jelena Budimir and Huljev, Eva and Luksic, Boris and Karabuva, Svjetlana and Cikes, Mihaela and Zambon, Maria}, year = {2019}, pages = {23}, DOI = {10.2807/1560-7917.ES.2019.24.1900121}, chapter = {1900121}, keywords = {Europe, influenza, multicentre study, test-negative design, vaccination, vaccine effectiveness, vaccines and immunisation.}, journal = {Eurosurveillance}, doi = {10.2807/1560-7917.ES.2019.24.1900121}, volume = {24}, number = {8}, issn = {1025-496X}, title = {Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019}, keyword = {Europe, influenza, multicentre study, test-negative design, vaccination, vaccine effectiveness, vaccines and immunisation.}, chapternumber = {1900121} }

Časopis indeksira:


  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.